Both in Pharmaceuticals
Alnylam Pharmaceuticals vs United Therapeutics
Over the past year ALNY returned −63.8% and UTHR returned +34.4%; their daily moves had a correlation of 0.02.
ALNY −63.8% UTHR +34.4%Growth of $1, one year, split-adjusted
| Metric | ALNY | UTHR |
|---|---|---|
| Price | $165.00 | $598.72 |
| Market cap | $22.10B | $25.68B |
| Today | −5.17% | +0.87% |
| 1 month | −28.6% | +4.8% |
| 6 months | −44.3% | +5.0% |
| Year to date | −58.5% | +22.9% |
| 1 year | −65.7% | +31.5% |
| Revenue growth (YoY) | +16.7% | −1.9% |
| Gross margin | 75.2% | 87.3% |
| Net margin | 148.6% | 42.5% |
| P/E (TTM) | 8.1× | 19.6× |
| Price / sales | 4.4× | 8.1× |
| Net cash | $2.57B | $2.66B |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 37.7% |
| Short % of float | 4.9% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).